Cost-effectiveness of perioperative nivolumab + neoadjuvant platinum doublet chemotherapy as treatment for resectable non-small cell lung cancer in the United States

Authors

Institutions

Publication Details

Journal
Journal of Medical Economics
Published
2025-04-20
DOI
https://doi.org/10.1080/13696998.2025.2494943
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effectiveness of perioperative nivolumab + neoadjuvant platinum doublet chemotherapy as treatment for resectable non-small cell lung cancer in the United States

Stefano Lucherini, Ariel Sun, Sandra Milev, Reginald Villacorta et al.
Journal of Medical Economics
Lung Cancer Diagnosis and Treatment
article

Cost-effectiveness of perioperative nivolumab + neoadjuvant platinum doublet chemotherapy as treatment for resectable non-small cell lung cancer in the United States

Stefano Lucherini, Ariel Sun, Sandra Milev, Reginald Villacorta, Benjamin White, M. Harris
article en

Abstract

No abstract available for this paper.
Journal of Medical EconomicsVol. 28(1)
Ithaka Harbors (US), Bristol-Myers Squibb (Germany) (DE)
Good health and well-being
Openalex Percentile: Top 87%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.